Valuation dashboard for BioXcel Therapeutics, Inc. (BTAI) with P/E N/A, P/B -0.01, EV/EBITDA -1.76 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
BioXcel Therapeutics, Inc. is a biopharmaceutical firm that has reached the commercial phase, distinguishing itself by leveraging artificial intelligence to advance the creation of transformative therapies in the fields of neuroscience and immuno-oncology.
Analysis Summary
Trailing-twelve-month margins: gross margin 45.3%, operating margin -60.1%, net margin -95.5%.
At the current price of $0.07, BTAI has negative trailing earnings (P/E not meaningful) and an ROE of 69.92%. Market capitalisation stands at $2M.
Balance sheet quality for BTAI: current ratio of 0.8. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | -0.01 |
| EV / EBITDA | -1.76 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-7.81 |
| vs Current Price | -10667.5% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| BTAI | BioXcel Therapeutics, Inc. | $2M | 69.9% | ||
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $0.07 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 69.92% |
| Return on Invested Capital | 1144.58% |
| Return on Assets | -246.05% |
| Gross Margin | 45.28% |
| Operating Margin | -6014.42% |
| Net Margin | -9549.87% |
Related companies: ANVS · BCAB · CELU · EVAX · GBIO · MAIA · MURA
Explore sector: Healthcare · Biotechnology
More sections of BTAI: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks